- Mannomustine
- Mannomustine dihydrochloride
- 55179-31-21H-1,2,4-Triazole-1-ethanol,b-([1,1'-biphenyl]-4-yloxy)-a-(1,1-dimethylethyl)-
- 55179-78-71H-Benzimidazole-1-carbonitrile,2-amino-
- 551-84-8D-threo-2-Pentulose
- 55-18-5Ethanamine,N-ethyl-N-nitroso-
- 5518-52-5Phosphine,tri-2-furanyl-
- 5518-62-7Phosphine,1,2-ethanediylbis- (9CI)
- 55186-89-55H-1,4-Diazepin-5-one,hexahydro-1-(phenylmethyl)-
- 55186-91-95H-1,4-Diazepin-5-one,hexahydro-1-phenyl-
- 551877-74-8TRANS-PERMETHRIN
- 551910-46-44H-Cyclopenta[b]thiophene-3-carboxylicacid, 2-[(3-chloro-1-oxopropyl)amino]-5,6-dihydro-, methyl ester
Hot Products
- 104987-11-3Tacrolimus
- 141-53-7Sodium formate
- 8001-54-5Quaternary ammonium compounds, alkylbenzyldimethyl, chlorides
- 9003-39-8Povidone
- 10161-34-9Trenbolone acetate
- 402957-28-2Telaprevir
- 68-19-9Cyanocobalamin
- 7631-86-9Silicon dioxide
- 302-79-4Tretinoin
- 77-92-9Citric acid
|
Basic Information |
|
Post buying leads |
|
Suppliers |
| Name |
Mannomustine dihydrochloride |
EINECS | 234-232-0 |
| CAS No. | 551-74-6 | Density | N/A |
| PSA | 104.98000 | LogP | 0.47260 |
| Solubility | N/A | Melting Point |
N/A |
| Formula | C10H22 Cl2 N2 O4 . 2 Cl H | Boiling Point | 541.9°C at 760 mmHg |
| Molecular Weight | 378.13 | Flash Point | 281.5°C |
| Transport Information | N/A | Appearance | N/A |
| Safety | Poison by intravenous, subcutaneous, and parenteral routes. Experimental reproductive effects. Questionable carcinogen with experimental carcinogenic and neoplastigenic data. Human mutation data reported. A drug used for the treatment of malignant neoplasms. When heated to decomposition it emits very toxic fumes of HCl and NOx. See also MANNOMUSTINE. | Risk Codes | N/A |
| Molecular Structure |
|
Hazard Symbols | N/A |
| Synonyms |
Mannitol,1,6-bis[(2-chloroethyl)amino]-1,6-dideoxy-, dihydrochloride, D- (8CI);1,6-Bis(chloroethylamino)-1,6-dideoxy-D-mannitol dihydrochloride;1,6-Bis(b-chlorethylamino)-1,6-didesoxy-D-mannitoldihydrochloride;1,6-Bis[(2-chloroethyl)amino]-1,6-dideoxy-D-mannitoldihydrochloride;Degranol;Degranol chinoin;Dimesylmannitol hydrochloride;Mannitol mustard dihydrochloride;Mannomustine dihydrochloride;Mannomustinehydrochloride;NSC 9698; |
Mannomustine dihydrochloride Chemical Properties
IUPAC Name: (2R,3R,4R,5R)-1,6-bis(2-Chloroethylamino)hexane-2,3,4,5-tetroldihydrochloride
Following is the structure of Mannomustine dihydrochloride (CAS NO.551-74-6):
Empirical Formula: C10H24Cl4N2O4
Molecular Weight: 378.1206
Flash Point: 281.5 °C
Enthalpy of Vaporization: 94.28 kJ/mol
Boiling Point: 541.9 °C at 760 mmHg
Vapour Pressure of Mannomustine dihydrochloride (CAS NO.551-74-6): 5.27E-14 mmHg at 25 °C
Canonical SMILES: C(CCl)NCC(C(C(C(CNCCCl)O)O)O)O.Cl.Cl
Isomeric SMILES: C(CCl)NC[C@H]([C@H]([C@@H]([C@@H](CNCCCl)O)O)O)O.Cl.Cl
InChI: InChI=1S/C10H22Cl2N2O4.2ClH/c11-1-3-13-5-7(15)9(17)10(18)8(16)6-14-4-2-12;/h7-10,13-18H,1-6H2;2*1H/t7-,8-,9-,10-;/m1../s1
InChIKey: GBKLAYXZNQSPBS-XYSQQLOGSA-N
Mannomustine dihydrochloride Toxicity Data With Reference
| 1. | cyt-hmn:lym 10 µmol/L | IPPABX Iugoslavica Physiologica et Pharmacologica Acta. 17 (1981),131. | ||
| 2. | sce-hmn:lym 3 µmol/L | IPPABX Iugoslavica Physiologica et Pharmacologica Acta. 17 (1981),131. | ||
| 3. | dnd-mus-ipr 200 mg/kg | FOBLAN Folia Biologica (Prague). 25 (1979),380. | ||
| 4. | hma-mus/esc 1 mg/kg | MUREAV Mutation Research. 21 (1973),190. | ||
| 5. | ipr-mus TDLo:23 mg/kg/4W:CAR | JNCIAM Journal of the National Cancer Institute. 36 (1966),915. | ||
| 6. | ipr-mus TDLo:7265 µg/kg/4W-I:NEO | JNCIAM Journal of the National Cancer Institute. 36 (1966),915. | ||
| 7. | par-rat LD50:56 mg/kg | RRCRBU Recent Results in Cancer Research. 52 (1975),76. | ||
| 8. | scu-mus LD50:120 mg/kg | RFECAC Revue Francaise dEtudes Cliniques et Biologiques. 7 (1962),296. | ||
| 9. | ivn-dog LDLo:7600 µg/kg | CCSUBJ Cancer Chemotherapy Reports, Part 2. 2 (1965),201. | ||
| 10. | ivn-mky LDLo:15 mg/kg | CCSUBJ Cancer Chemotherapy Reports, Part 2. 2 (1965),201. |
Mannomustine dihydrochloride Consensus Reports
IARC Cancer Review: Group 3 IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man . 7 ,1987,p. 56.(World Health Organization, Internation Agency for Research on Cancer,Lyon, France.: ) (Single copies can be ordered from WHO Publications Centre U.S.A., 49 Sheridan Avenue, Albany, NY 12210) ; Animal Sufficient Evidence IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man . 9 ,1975,p. 157.(World Health Organization, Internation Agency for Research on Cancer,Lyon, France.: ) (Single copies can be ordered from WHO Publications Centre U.S.A., 49 Sheridan Avenue, Albany, NY 12210) .
Mannomustine dihydrochloride Safety Profile
Poison by intravenous, subcutaneous, and parenteral routes. Experimental reproductive effects. Questionable carcinogen with experimental carcinogenic and neoplastigenic data. Human mutation data reported. A drug used for the treatment of malignant neoplasms. When heated to decomposition, Mannomustine dihydrochloride (CAS NO.551-74-6) emits very toxic fumes of HCl and NOx. See also MANNOMUSTINE.
Mannomustine dihydrochloride Specification
Mannomustine dihydrochloride , its cas register number is 551-74-6. It also can be called 1,6-Bis(beta-chloroethylamino)-1,6-dideoxy-D-mannitol dihydrochloride ; 1,6-Bis(chloroethylamino)-1,6-desoxymannitol dihydrochloride ; 1,6-Dideoxy-1,6-di(2-chloroethylamino)-D-mannitol dihydrochloride ; Degranol ; and Degranol chinoin . Its classification code are Drug / Therapeutic Agent; Mutation data; Reproductive Effect and Tumor data.
What can I do for you?
Get Best Price
